Senior Financial Analyst, Commercial Skeletal FP&A

Join to apply for the Senior Financial Analyst, Commercial Skeletal Conditions FP&A role at Bio Space

1 day ago Be among the first 25 applicants

Join to apply for the Senior Financial Analyst, Commercial Skeletal Conditions FP&A role at Bio Space

Who We Are

Bio Marin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.

Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

About Corporate Groups

It takes a village, and at Bio Marin our corporate groups are the people behind our success. Groups such as IT, Finance, Legal, Global Compliance & Ethics, and our People Team provide foundational support of all areas of operation at Bio Marin.

Bio Marin Financial Planning & Analysis (FP&A) teamis seeking a highly motivated Senior Financial Analyst to join their team. This position will be a key member of a cross-functional, multi-national team supporting Bio Marin’s Skeletal Conditions Business Unit, with an emphasis on the Commercial organization. Reporting to the Skeletal Conditions Director of FP&A, the Senior Financial Analyst will play a critical role in driving BU financial planning, P&L management and reporting.

This individual will help develop robust analytics and critical insights that drive enterprise-wide strategic business decisions and ensure alignment with strategic objectives. The successful candidate will gain significant exposure to business operations, strategic decision-making processes and key Executive Leadership, contributing to the development and execution of business strategies. Responsibilities:
The FP&A team is responsible for the consolidation, reporting, and analysis of the company’s budget and forecasts for both Revenue and Operating Expenses (OpEx). The Senior Financial Analyst will lead various aspects of FP&A, including:
Budget and Forecast Process:
Manage the annual budget, forecasting and long-range planning processes, including the development of templates, timelines, and communications; consolidation of business inputs and detailed analysis of the combined budget.

Stakeholder Management:
Finance business partner to cost centers/budget owners, supporting key investment decisions and spend analysis; prepare and present (as necessary) management updates for Executive team.

Key Reports and Financial Packages:
Prepare and present comprehensive financial packages for senior management, highlighting key insights and trends.

Monthly Financial Reporting:
Preparation of monthly financial reports, including variance analysis to assess performance against budget and or Forecasts.

Process Improvement:
Drive ongoing process improvement and automation projects within the finance team to enhance efficiency and accuracy.

Cross Functional Liaison on P&L with Technical Operations (TOPS) and Worldwide R&D (WWRD) on OpEx.

Ad Hoc Reporting and Analysis:
Conduct detailed analyses and provide insights to support strategic decision-making.

Experience Desired

• 3+ years of experience in complicated corporate finance environments (preferably in-house corporate finance)
• A grasp of the biopharma industry and its complex, highly regulated landscape is desirable; experience in other healthcare segments is also…